Sight Sciences (SGHT) to Expand in Europe With New Launch
https://www.zacks.com/stock/news/2229444/sight-sciences-sght-to-expand-in-europe-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229444
Feb 21, 2024 - By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
0
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2230219/why-cardinal-health-cah-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2230219
Feb 22, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status
https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299
Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
0
ICON (ICLR) Gains From Strategic Deals, New Innovations
https://www.zacks.com/stock/news/2235446/icon-iclr-gains-from-strategic-deals-new-innovations?cid=CS-ZC-FT-analyst_blog|zer_report_update-2235446
Mar 04, 2024 - ICON (ICLR) continues to evolve its collaboration and delivery models, invest in technology, and enhance its project and program management capabilities.
0
CVS Health (CVS) Expands In-Home Diagnostic Care With New Test
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
0
Reasons to Retain Prestige Consumer (PBH) Stock for Now
https://www.zacks.com/stock/news/2236222/reasons-to-retain-prestige-consumer-pbh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2236222
Mar 05, 2024 - Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
0
Lantheus' (LNTH) DEFINITY Approved by FDA for Pediatric Use
https://www.zacks.com/stock/news/2236099/lantheus-lnth-definity-approved-by-fda-for-pediatric-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236099
Mar 05, 2024 - Lantheus' (LNTH) receipt of the expanded indication for DEFINITY is likely to address unmet medical needs of pediatric patients.
0
DaVita (DVA) Expands Operational Footprint Via New Agreement
https://www.zacks.com/stock/news/2236716/davita-dva-expands-operational-footprint-via-new-agreement?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236716
Mar 06, 2024 - DaVita's (DVA) latest agreement is expected to serve a wider patient pool across Latin America.
0
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
https://www.zacks.com/stock/news/2236660/are-investors-undervaluing-cardinal-health-cah-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2236660
Mar 06, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0